Lymphoma & CLL: Managing Side Effects & Building Trust
- Barcelona,Spain — Patients with lymphoma and chronic lymphocytic leukemia (CLL) often experience adverse effects that,if not properly addressed,can significantly impact their well-being and confidence in their treatment plans.
- Warwick highlighted findings from the Lymphoma Coalition's 2024 Global Patient Survey, which included over 11,000 responses.
- The survey revealed that fatigue is the most prevalent side effect, frequently underestimated by healthcare professionals.
unaddressed side effects considerably impact lymphoma and CLL patients, eroding their confidence in care. A recent study reveals fatigue is the most prevalent,often overlooked primary_keyword. Learn how better communication and proactively addressing secondary_keyword side effects can build trust and improve patient outcomes. Open dialogue, even without full resolution, is key. This insight from News Directory 3 stresses the importance of addressing these challenges. Discover what’s next …
Unaddressed Side Effects diminish Confidence in Lymphoma,CLL Care
Updated June 15,2025
Barcelona,Spain — Patients with lymphoma and chronic lymphocytic leukemia (CLL) often experience adverse effects that,if not properly addressed,can significantly impact their well-being and confidence in their treatment plans. Lorna Warwick, CEO of the Lymphoma Coalition, discussed these issues at the European Hematology Association 2025 Congress.
Warwick highlighted findings from the Lymphoma Coalition’s 2024 Global Patient Survey, which included over 11,000 responses. A key analysis focused on more than 6,600 patients who reported side effects from their illness. The study examined the impact of unaddressed side effects on patient confidence in their doctors and care plans.
The survey revealed that fatigue is the most prevalent side effect, frequently underestimated by healthcare professionals. Warwick noted that fatigue often persists long after treatment, exacerbating the patient experience. Other common side effects include nausea, constipation, and diarrhea, which can significantly affect a patient’s quality of life.
The study’s objective was to understand how addressing or failing to address these side effects influences patient confidence. The results indicated a clear correlation: when side effects are not adequately addressed, patient confidence decreases, leading to increased hospitalizations and a negative impact on healthcare systems.
Warwick emphasized the importance of open communication between patients and clinicians. Even when a complete resolution of side effects is not possible, a supportive dialogue can significantly improve patient confidence. This includes actively listening to patients, addressing their questions, and ensuring they understand the data provided.
“Raising that confidence level of patients is really vital, and one of the ways to do that is to actually address the issues that a patient is raising,” Warwick said.
What’s next
The Lymphoma Coalition plans to continue its global patient surveys to further understand and address the challenges faced by lymphoma and CLL patients, focusing on improving communication and support systems to enhance patient confidence and overall well-being.